Feline leukemia virus (FeLV) infects between 2% and 3% of all cats in the United States and Canada. That number has dropped significantly over the past few decades thanks to effective vaccines and routine testing, but FeLV remains one of the most important infectious diseases in cats.
ProcedureCats were tested with a point-of-care ELISA for FeLV antigen and FIV antibody. A multivari-able random effects logistic regression model was used to identify risk factors significantly associated with seropositivity while accounting for clinic-to-clinic (or shelter) variability.
Combining the results of whole blood antigen testing, PetChek and qPCR identified cats as high positive, low positive or cryptic/negative, with high positive cats having higher risk for early mortality. Use of these diagnostic tools facilitates the management of FeLV as a chronic condition.
Furthermore, visual representations like the one above help us fully grasp the concept of Feline Leukemia Virus In Cats Statistics.
FeLV and FIV infections were observed in 26.9% and 13.5% of necropsied cats, respectively. FeLV-infected cats died younger than uninfected ones. The odds of diagnosing leukemia and lymphoma were 19.4 and 3.9 times higher in cats with FeLV, respectively.
Overall, the aim of the present study was to provide an overview of the prevalence of FeLV and FIV infections in different cat populations living in several regions of southern Italy and to evaluate the risk factors (year, location and lifestyle) likely related FeLV and/or FIV positivity.
